New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the treatment of COVID-19.
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its Phase III trials data on Tuesday, according to sources.
New Delhi [India], June 22 (ANI): The Subject Expert Committee (SEC) under the drug regulator will discuss reviewing the Phase III data of Bharat Biotech's Covaxin on Tuesday.
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
New Delhi [India], May 26 (ANI): MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of COVID-19 in India.
Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients.
Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms.
New Delhi [India], May 15 (ANI): Since the beginning of Phase III of the vaccination drive in India, more than 42 lakh beneficiaries of age group 18-44 have been given the first dose of COVID-19 vaccine, the Ministry of Health and Family Welfare said on Saturday.
New Delhi [India], May 5 (ANI): The Union Cabinet on Wednesday approved the allocation of additional foodgrain to NFSA beneficiaries under Pradhan Mantri Garib Kalyan Anna Yojana (Phase III) for a period of two months -- May and June 2021.
New Delhi [India], May 4 (ANI): More than four lakh beneficiaries, belonging to the age group of 18-44 years have been vaccinated till date since the third phase of the vaccination drive commenced on Saturday, informed the government on Tuesday morning.
New Delhi [India], May 1 (ANI): India will start the vaccination drive for those in the 18-44 age bracket from Saturday as the country continues to battle the second wave of COVID-19.